Literature DB >> 2651136

Inhibition of erythropoiesis by a soluble factor in murine malaria.

K L Miller1, J C Schooley, K L Smith, B Kullgren, L J Mahlmann, P H Silverman.   

Abstract

To study the cellular mechanisms involved in the ineffective erythropoiesis associated with malaria, an in vitro proliferative assay was used to measure the response to erythropoietin (Epo) of erythroid progenitor cells from malaria-infected mice. In this assay, spleen (SP) cells from phenylhydrazine (PHZ)-treated mice (PHZ-SP), enriched for erythroid progenitor cells, respond to Epo in a dose-dependent manner. Despite a similar degree of anemia, SP and bone marrow (BM) cells from Plasmodium berghei- or P. vinckei-infected mice did not show a significant response to Epo in this assay. When SP or BM cells from malaria-infected mice were added to cultures of SP or BM cells from PHZ-treated mice the response to Epo of these cells was significantly inhibited. Removal of parasitized red blood cells (pRBC) from SP cells of P. berghei-infected mice had no effect on the ability of the cells to inhibit the response to Epo. Adherent SP cells and SP cells positive for the Mac-1 antigen, from malaria-infected mice, were shown to be enriched for cells that could inhibit the response to Epo. Cell-free conditioned media (CM) prepared from SP cells of P. berghei- or P. vinckei-infected mice or from normal SP cells incubated with pRBC were also able to inhibit the response to Epo of SP cells from PHZ-treated mice. These investigations have shown that during the course of malaria infection, cells appear in the SP and BM capable of inhibiting, via soluble mediators, the response to Epo of erythroid progenitor cells. The cells responsible are probably macrophages. The nature of the factor(s) and its mechanism of action are not known. Through the ability to inhibit erythropoiesis, soluble factors may, in part, mediate the anemia associated with malaria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651136

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  10 in total

1.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

2.  Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Authors:  J A Martiney; B Sherry; C N Metz; M Espinoza; A S Ferrer; T Calandra; H E Broxmeyer; R Bucala
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Tumor necrosis factor alpha and the anemia associated with murine malaria.

Authors:  K L Miller; P H Silverman; B Kullgren; L J Mahlmann
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

4.  Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumor necrosis factor alpha, and gamma interferon.

Authors:  G S Yap; M M Stevenson
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

Authors:  Wattana Leowattana; Srivicha Krudsood; Noppadon Tangpukdee; Gary Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2008-07       Impact factor: 0.267

6.  Cytokine dysregulation associated with malarial anemia in Plasmodium yoelii infected mice.

Authors:  Lili Xu; Xiaoying Zheng; Klavs Berzins; Asok Chaudhuri
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

7.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

Authors:  Michael A McDevitt; Jianlin Xie; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; Jeffrey Keefer; John David; Lin Leng; Richard Bucala
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

Review 8.  Erythropoiesis in Malaria Infections and Factors Modifying the Erythropoietic Response.

Authors:  Vrushali A Pathak; Kanjaksha Ghosh
Journal:  Anemia       Date:  2016-02-29

9.  A brief review on features of falciparum malaria during pregnancy.

Authors:  Alexandre Manirakiza; Eugène Serdouma; Richard Norbert Ngbalé; Sandrine Moussa; Samuel Gondjé; Rock Mbetid Degana; Gislain Géraud Banthas Bata; Jean Methode Moyen; Jean Delmont; Gérard Grésenguet; Abdoulaye Sepou
Journal:  J Public Health Afr       Date:  2017-12-31

10.  Morphological and Transcriptional Changes in Human Bone Marrow During Natural Plasmodium vivax Malaria Infections.

Authors:  Marcelo A M Brito; Bàrbara Baro; Tainá C Raiol; Alberto Ayllon-Hermida; Izabella P Safe; Katrien Deroost; Erick F G Figueiredo; Allyson G Costa; Maria Del P Armengol; Lauro Sumoy; Anne C G Almeida; Bidossessi W Hounkpe; Erich V De Paula; Cármen Fernandez-Becerra; Wuelton M Monteiro; Hernando A Del Portillo; Marcus V G Lacerda
Journal:  J Infect Dis       Date:  2022-04-01       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.